Clinical Trial Update: High Versus Low LMWH Dosages in Hospitalized Patients With Severe COVID-19 Pneumonia and Coagulopathy [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing high versus low doses of low-molecular-weight heparin in hospitalized patients with severe COVID-19 pneumonia and coagulopathy; status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia

Snippet

Sponsor: Azienda Ospedaliero-Universitaria di Modena | Conditions: COVID, Pneumonia, Viral | Phase 3 | Status: UNKNOWN